Welcome to our dedicated page for Kindly Md news (Ticker: KDLY), a resource for investors and traders seeking the latest updates and insights on Kindly Md stock.
The KDLY news page tracks public updates and announcements from KindlyMD, Inc., a patient-first healthcare and healthcare data company whose stock is listed on Nasdaq. Company news highlights its integrated healthcare services, value-based care initiatives, and its evolving corporate strategy that combines healthcare operations with a planned Bitcoin treasury focus through a definitive merger agreement with Nakamoto Holdings Inc.
Readers can find coverage of quarterly and interim financial results, where KindlyMD reports on revenues, reimbursements from insurance payers, operating expenses, and net income or loss. These releases often include operational highlights such as expansion of insurance credentialing, growth in in-network coverage in Utah, and the development of enterprise-level data analytics to support evidence-based, personalized care.
News items also describe clinical and operational milestones, including the opening of new integrated behavioral health clinics in Utah and the expansion of contracts with major insurers such as Medicare, Medicaid, Select Health, Blue Cross Blue Shield, Cigna Healthcare, and UnitedHealthcare. These updates outline how increased insurance coverage broadens patient access and supports KindlyMD’s alternative pain treatment model.
Another key news theme is the company’s strategic transactions and financing. Releases detail the definitive merger agreement with Nakamoto Holdings, related PIPE and convertible note financings, and a strategic partnership with Anchorage Digital for Bitcoin custody and trading services tied to a planned Bitcoin treasury strategy. Additional announcements include a share repurchase program authorized by the board of directors.
Investors and observers can use this news feed to follow KindlyMD’s progress in integrated healthcare services, its role in alternative pain treatment and medical cannabis recommendations in Utah, and its transition toward a combined healthcare and Bitcoin treasury platform as described in its public communications.
KindlyMD (NASDAQ:KDLY), a healthcare firm integrating primary care, pain management, and alternative therapies, has contracted with Blue Cross Blue Shield, securing nearly 80% comprehensive insurance coverage statewide in Utah. The company is one of the first alternative medical treatment providers in Utah to achieve this status, adding to its existing contracts with Select Health, Medicare, and Medicaid. This expanded coverage is expected to increase patient volume and revenue across all clinics. Founded by Tim Pickett, PA-C, KindlyMD aims to address the opioid crisis by offering non-opioid treatments and medical cannabis education. To date, it has treated over 60,000 patients and remains dedicated to providing accessible, quality behavioral healthcare.
KindlyMD announced a strategic collaboration with Curaleaf to expand medical cannabis education in Utah. The partnership aims to offer holistic pain management and alternative therapies. Community care events will be held throughout the summer at Curaleaf's medical cannabis pharmacies in Lehi, Provo, and Payson. These events aim to educate patients on medical cannabis as a safer, more affordable option for pain management. KindlyMD's Complete Care program will be introduced, offering easier access to medical cannabis care. This initiative aligns with efforts to combat the opioid crisis and promote sustainable healthcare options.
KindlyMD, a healthcare company merging traditional and alternative therapies, announced its credentialing and contracting with Utah's top insurance payors, including Medicare, Medicaid, and Select Health. This achievement makes KindlyMD the first alternative medical treatment firm in Utah to achieve this coverage, which spans nearly 70% of the state's insured individuals. This milestone enables KindlyMD to expand its patient base and revenue by offering reimbursable services, including behavioral healthcare and alternative medicine interventions. The company has treated over 60,000 patients in its clinics.
KindlyMD, a healthcare company listed on NASDAQ under the ticker KDLY, will present at the KCSA Cannabis Virtual Investor Conference on June 5th, 2024. The presentation will be led by CEO Tim Pickett at 3 p.m. ET. KindlyMD integrates traditional primary care, pain management, and alternative therapies, including medical cannabis, in compliance with state regulations. Investors can register online and access an archived webcast if they miss the live event.
WallachBeth Capital announced the successful completion of KindlyMD's IPO, raising $6.8 million in gross proceeds. The IPO involved the sale of 1,240,910 units at $5.50 each. Each unit includes one share of common stock, one tradeable warrant, and one non-tradeable warrant. The shares and tradeable warrants began trading on Nasdaq under the symbols 'KDLY' and 'KDLYW'. Additionally, KindlyMD has granted underwriters a 45-day option to purchase up to an additional 186,136 shares and warrants to cover over-allotments. WallachBeth Capital served as the Sole Bookrunner for the offering.
KindlyMD (NASDAQ:KDLY, KDLYW) has completed its initial public offering (IPO) of 1,240,910 units at $5.50 per unit, raising approximately $6.8 million in gross proceeds. Each unit includes one share of common stock, one tradeable warrant to purchase a share at $6.33, and one non-tradeable warrant to purchase half a share at $6.33. The shares and warrants began trading on Nasdaq on May 31, 2024. WallachBeth Capital is the sole bookrunner. KindlyMD has also granted underwriters a 45-day option to purchase additional shares and warrants to cover over-allotments.
KindlyMD (NASDAQ: KDLY; KDLYW) announced the pricing of its $6.8 million IPO on May 31, 2024. The IPO consists of 1,240,910 units priced at $5.50 per unit, each unit comprising one share of common stock, one tradeable warrant, and one non-tradeable warrant. The tradeable warrants and non-tradeable warrants both have an exercise price of $6.33 per share. The shares and tradeable warrants will trade on Nasdaq under the symbols 'KDLY' and 'KDLYW,' respectively. The offering is expected to close around June 3, 2024, subject to customary conditions. WallachBeth Capital is the sole bookrunner for this offering, and the underwriters have a 45-day option to purchase additional securities to cover over-allotments.
KindlyMD has announced the pricing of its Initial Public Offering (IPO) at $5.50 per unit, totaling approximately $6.8 million in gross proceeds. Each unit contains one share of common stock, one tradeable warrant, and one non-tradeable warrant. The common stock and tradeable warrants will start trading on NASDAQ under the symbols 'KDLY' and 'KDLYW' on May 31, 2024. The offering is expected to close on June 3, 2024, subject to customary conditions. KindlyMD has also granted underwriters a 45-day option to purchase additional shares and warrants to cover over-allotments. WallachBeth Capital is the sole bookrunner for the offering.